TP53 and acute myeloid leukemia: Remarkably, TP53 alterations were found to be associated with the most dismal prognosis, even compared to high-risk FGs and other adverse cytogenomic features (Fig. 5b), further underscoring the importance of identifying these aberrations in pediatric AML patients.